DK1222207T3 - C-peptid til forbedret fremstilling af insulin og insulinanaloge - Google Patents

C-peptid til forbedret fremstilling af insulin og insulinanaloge

Info

Publication number
DK1222207T3
DK1222207T3 DK00960664T DK00960664T DK1222207T3 DK 1222207 T3 DK1222207 T3 DK 1222207T3 DK 00960664 T DK00960664 T DK 00960664T DK 00960664 T DK00960664 T DK 00960664T DK 1222207 T3 DK1222207 T3 DK 1222207T3
Authority
DK
Denmark
Prior art keywords
insulin
chain
amino acid
human insulin
peptide
Prior art date
Application number
DK00960664T
Other languages
English (en)
Inventor
Paul Habermann
Johannes Meiwes
Gerhard Seipke
Johann Ertl
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1222207T3 publication Critical patent/DK1222207T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00960664T 1999-10-02 2000-09-15 C-peptid til forbedret fremstilling af insulin og insulinanaloge DK1222207T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947456A DE19947456A1 (de) 1999-10-02 1999-10-02 C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga
PCT/EP2000/009017 WO2001025278A1 (de) 1999-10-02 2000-09-15 C-peptid zur verbesserten herstellung von insulin und insulinanaloga

Publications (1)

Publication Number Publication Date
DK1222207T3 true DK1222207T3 (da) 2008-03-17

Family

ID=7924253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00960664T DK1222207T3 (da) 1999-10-02 2000-09-15 C-peptid til forbedret fremstilling af insulin og insulinanaloge

Country Status (25)

Country Link
US (1) US6534288B1 (da)
EP (1) EP1222207B1 (da)
JP (1) JP4681784B2 (da)
KR (1) KR100823463B1 (da)
CN (1) CN1193042C (da)
AT (1) ATE380196T1 (da)
AU (1) AU778369B2 (da)
BR (2) BRPI0014464B8 (da)
CA (1) CA2385857C (da)
CY (1) CY1107860T1 (da)
DE (2) DE19947456A1 (da)
DK (1) DK1222207T3 (da)
ES (1) ES2295054T3 (da)
HK (1) HK1049016B (da)
HU (1) HU228313B1 (da)
IL (2) IL148942A0 (da)
MX (1) MXPA02003103A (da)
NO (1) NO329975B1 (da)
NZ (1) NZ518066A (da)
PL (1) PL203195B1 (da)
PT (1) PT1222207E (da)
SI (1) SI1222207T1 (da)
TW (1) TWI265168B (da)
WO (1) WO2001025278A1 (da)
ZA (1) ZA200202520B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20050250676A1 (en) * 2001-11-19 2005-11-10 Aventis Pharma Deutschland Gmbh Method of activating insulin receptor substrate-2 to stimulate insulin production
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
CN102816228A (zh) * 2003-12-03 2012-12-12 诺和诺德公司 单链胰岛素
CN1663960B (zh) * 2004-03-01 2012-07-04 重庆富进生物医药有限公司 高效表达重组人胰岛素原及其类似物的新型c肽
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
DE102008003566A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
EP2229407B1 (de) 2008-01-09 2016-11-16 Sanofi-Aventis Deutschland GmbH Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
JP5695909B2 (ja) * 2008-01-09 2015-04-08 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
DE102008003568A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025007A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025008A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
CN105899190B (zh) 2014-01-09 2022-06-14 赛诺菲 门冬胰岛素的稳定化药物制剂
AU2015205624A1 (en) 2014-01-09 2016-07-14 Sanofi Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604708VA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
PL3229828T3 (pl) 2014-12-12 2023-07-31 Sanofi-Aventis Deutschland Gmbh Formulacja o ustalonym stosunku insuliny glargine/liksysenatydu
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16156A (en) * 1980-03-27 1983-07-18 Lilly Co Eli Process for producing an insulin precursor
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
DK0821006T3 (da) * 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung

Also Published As

Publication number Publication date
PT1222207E (pt) 2008-02-11
NO329975B1 (no) 2011-01-31
MXPA02003103A (es) 2002-09-30
AU7287700A (en) 2001-05-10
PL203195B1 (pl) 2009-09-30
CN1377370A (zh) 2002-10-30
SI1222207T1 (sl) 2008-04-30
BR0014464A (pt) 2002-06-11
AU778369B2 (en) 2004-12-02
CA2385857A1 (en) 2001-04-12
NO20021335L (no) 2002-06-03
ATE380196T1 (de) 2007-12-15
KR20020047209A (ko) 2002-06-21
WO2001025278A1 (de) 2001-04-12
BRPI0014464B8 (pt) 2021-05-25
PL354078A1 (en) 2003-12-15
HK1049016B (zh) 2005-10-14
BRPI0014464B1 (pt) 2018-03-13
JP4681784B2 (ja) 2011-05-11
EP1222207B1 (de) 2007-12-05
HUP0202755A3 (en) 2005-01-28
US6534288B1 (en) 2003-03-18
CN1193042C (zh) 2005-03-16
IL148942A0 (en) 2002-09-12
NO20021335D0 (no) 2002-03-18
EP1222207A1 (de) 2002-07-17
HK1049016A1 (en) 2003-04-25
JP2003511018A (ja) 2003-03-25
NZ518066A (en) 2004-05-28
CA2385857C (en) 2012-05-22
ZA200202520B (en) 2002-12-24
HU228313B1 (en) 2013-03-28
ES2295054T3 (es) 2008-04-16
HUP0202755A2 (hu) 2002-12-28
KR100823463B1 (ko) 2008-04-21
CY1107860T1 (el) 2013-06-19
IL148942A (en) 2010-02-17
DE50014830D1 (de) 2008-01-17
TWI265168B (en) 2006-11-01
DE19947456A1 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
DK1222207T3 (da) C-peptid til forbedret fremstilling af insulin og insulinanaloge
BR9906796A (pt) Método para a administração de análogos de insulina monoméricos
ATE124997T1 (de) Enzymatische entfernung einer aminoterminalen proteinsequenz.
SE0002102D0 (sv) Chemical compound
HUP9801886A2 (hu) Eljárás megfelelően kapcsolódó cisztinhidakat tartalmazó inzulin-prekurzorok előállítására
HUP0100243A2 (hu) Inzulint és/vagy inzulin-analógokat és azok származékait tartalmazó oldhatatlan készítmények, eljárás azok előállítására és alkalmazásuk a vércukor szintjének szabályozására
EP1423111A4 (en) FXR NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
DE60233722D1 (de) Insulinvorstufen und verfahren zu deren herstellung
ATE389662T1 (de) Cardioprotektive phosphonate
DK1439830T3 (da) Farmaceutisk præparat med 2-(4-isobutylphenyl)propionsyre
WO2005066207A8 (en) Glucagon-like peptide-1 analogs with long duration of action
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MA27982A1 (fr) Preparation de peptides somatostatine
DK120290D0 (da) Nye derivater af human/bovin basal fibroblastvaekstfaktor
ATE482272T1 (de) Zytokinproteinfamilie
BR9714066A (pt) Processo para a preparação de derivados de tiazol.
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
DE60227421D1 (de) Rmazeutische zusammensetzung und verwendung davon
SE0101978D0 (sv) New compounds
DE60325631D1 (de) Verfahren zur herstellung von 2,6-dihalo-para-trifluoromethylanilin
SE0201938D0 (sv) New process
WO2001064715A3 (en) Memno peptides, a process for their preparation and their use
HUP0202793A2 (hu) A humán inzulin monomer analógjai
HUP0103194A2 (hu) 17-Halogénezett-19-nor-szteroidok, eljárás azok előállítására, az azokat tartalmazó gyógyszerkészítmények, valamint intermedierjeik